Real Word Evidence of the Effectiveness of the Treatment of Antibody Mediated Rejection in Kidney Transplant Recipients

被引:0
|
作者
Divard, G. [1 ]
Naser, S. [1 ]
Al-Awadhi, S. [1 ]
Debiais, C. [1 ]
Maanaoui, M. [2 ]
Juric, I. [3 ]
Castro, M. R. [4 ]
Kamar, N. [5 ]
Gueguen, J. [6 ]
Crespo, M. [7 ]
Aubert, O. [1 ]
Alexandre, L. [1 ]
Lefaucheur, C. [1 ]
机构
[1] Paris Transplant Grp, Paris, France
[2] CHU Lille, Lille, France
[3] Univ Hosp Ctr Zagreb, Zagreb, Croatia
[4] Univ Sao Paulo, Hosp Clin, Fac Med, Sao Paulo, Brazil
[5] CHU Toulouse, Toulouse, France
[6] CHU Tours, Tours, France
[7] Hosp Mar, Nephrol & Kidney Transplantat, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
151
引用
收藏
页码:S411 / S412
页数:2
相关论文
共 50 条
  • [31] Treatment and Outcomes of Kidney Transplant Recipients with C4d Negative Antibody Mediated Rejection
    Walsh, M.
    Lineberger, L.
    Brokhof, M.
    Kenyon, N.
    Alvey, N.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 734 - 734
  • [32] Outcomes in Kidney Transplant Recipients With Post-Transplant DSA in the Absence of Antibody Mediated Rejection
    Osadchuk, L.
    Astor, B.
    Ellis, T.
    Kaufman, D.
    Brar, J.
    Djamali, A.
    Muth, B.
    Mohamed, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 467 - 467
  • [33] Effectiveness of IVIG Prophylaxis Against Antibody Mediated Rejection in Sensitized Renal Transplant Recipients
    Cyprich, J.
    Biondi, L.
    Cirocco, R.
    Moritz, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 129 - 129
  • [34] Effectiveness of IVIG Prophylaxis Against Antibody Mediated Rejection in Sensitized Renal Transplant Recipients
    Cyprich, J.
    Biondi, L.
    Cirocco, R.
    Moritz, M.
    [J]. TRANSPLANTATION, 2014, 98 : 129 - 129
  • [35] Conversion to Belatacept in kidney transplant recipients with chronic antibody-mediated rejection (CAMR)
    Moein, Mahmoudreza
    Gao, Shuqi X.
    Martin, Samuel J.
    Farkouh, Katie M.
    Li, Benson W.
    Ball, Angela S.
    Dvorai, Reut Hod
    Saidi, Reza F.
    [J]. TRANSPLANT IMMUNOLOGY, 2023, 76
  • [36] Antibody Mediated Rejection in Kidney Transplant Recipients with and without Donor Specific Antibodies.
    Miguel, M.
    Lai, J.
    Bray, R.
    Eckels, D.
    Gebel, H.
    Bry, W.
    Katznelson, S.
    Peddi, V. R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 297 - 297
  • [37] Outcomes of Acute and Chronic Antibody-Mediated Allograft Rejection in Kidney Transplant Recipients
    Al Jurdi, Ayman
    Cyrino, Laura Goldfarb
    Lafargue, Marie-Camille
    Riella, Leonardo V.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 652 - 652
  • [38] Outcomes of Kidney Transplant Recipients with Antibody-mediated Allograft Rejection: A Retrospective Study
    Al Jurdi, A.
    Goldfarb, L.
    Lafargue, M.
    Azzi, J.
    Riella, L. V.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 728 - 728
  • [39] Carfilzomib-based antibody mediated rejection therapy in pediatric kidney transplant recipients
    Cody, Ellen M.
    Varnell Jr, Charles
    Lazear, Danielle
    VandenHeuvel, Katherine
    Flores, Francisco X.
    Woodle, E. Steve
    Hooper, David K.
    [J]. PEDIATRIC TRANSPLANTATION, 2023, 27 (07)
  • [40] Complement classical pathway monitoring for the detection of antibody mediated rejection in kidney transplant recipients
    Mezo, Blanka
    Heilos, Andreas
    Boehmig, Georg
    Eskandary, Farsad
    Wahrmann, Markus
    Bond, Gregor
    Halloran, Philip F.
    Rusai, Krisztina
    Prohaszka, Zoltan
    [J]. MOLECULAR IMMUNOLOGY, 2018, 102 : 189 - 189